Jefferies Financial Group’s iRadimed IRMD Stock Holding History

Jefferies Financial Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$731K	Buy	+7,599	New	+$760K	0.01%	1046

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Financial Group's IRMD Position: Q1 2026 in Review

Jefferies Financial Group opened a new position in iRadimed (IRMD) in Q1 2026: 7,599 shares worth $731K. The stake represents 0.01% of the portfolio and ranks #1046 among its holdings.

228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Jefferies Financial Group held 7,599 shares of iRadimed worth $731K as of Q1 2026.
iRadimed was a new Jefferies Financial Group position in Q1 2026.
iRadimed made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1046 holding.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.